Hereditary progressive mucinous histiocytosis

Journal of the American Academy of Dermatology

Volumn 35, Issue 2 II, 1996, Pages 298-303

  Schröder, Kathrin ^a   Hettmannsperger, Uwe ^a   Schmuth, Matthias ^a   Orfanos, Constantin E ^a   Goerdt, Sergij ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ELECTRON MICROSCOPY; FEMALE; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0030017697     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90653-2     Document Type: Article

References (42)

1. Bork K, Hoede N. Hereditary progressive mucinous histiocytosis in women. Arch Dermatol 1988;124:1225-9.
2. Bork K. Hereditary progressive mucinous histiocytosis: immunohistochemical and ultrastructural studies in an additional family. Arch Dermatol 1994;130:1300-4.
3. Iglesias-Diez L, Lopez-Gomes S, Guerra-Tapia A, et al. Familial progressive nodular histiocytoma. Presented at the 17th World Congress of Dermatology; May 24-29, 1987, Berlin, Germany.
4. Goerdt S, Kolde G, Bonsmann G, et al. Immunohistochemical comparison of cutaneous histiocytoses and related skin disorders: diagnostic and histogenetic relevance of MS-1 high molecular weight protein expression. J Pathol 1993; 170:421-7.
5. Kodelja V, Goerdt S. Dissection of macrophage differentiation pathways in cutaneous macrophage disorders and in vitro. Exp Dermatol 1994;3:257-68.
6. Fartasch M, Goerdt S, Hornstein O. Chancen und Grenzen paraffingängiger Zellmarker in der Diagnostik primärer kutaner Histiozytosen. Hautarzt 1995;46:144-53.
7. The Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet 1987;1:208-9.
8. Winkelmann RK. Cutaneous syndromes of non-X histiocytosis. Arch Dermatol 1981;117:667-72.
9. Ringel E, Moschella S. Primary histiocytic dermatoses. Arch Dermatol 1985;121:1531-41.
10. Gianotti F, Caputo R. Histiocytic syndromes: a review. J Am Acad Dermatol 1995;13:383-404.
11. Smith KJ, Skelton HG, Yeager J, et al. Cutaneous histopathologic, immunohistochemical, and clinical manifestations in patients with hemophagocytic syndrome. Military Medical Consortium for Applied Retroviral Research. Arch Dermatol 1992;128:193-200.
12. Henter J-I, Blinder G, Öst A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18:29-33.
13. Goerdt S, Fartasch M, Kodelja V, et al. Histiozytosen: Klassifikation und zelluläre Pathobiologie. In: Macher E, Bröcker E-B, Kolde G, eds. Jahrbuch für Dermatologie 1994/95. Zülpich: Biermann Verlag GmbH, 1994;175-195.
14. Goerdt S, Walsh LJ, Murphy GF, et al. Identification of a novel high molecular weight protein antigen preferentially expressed by sinusoidal endothelial cells in normal human tissues. J Cell Biol 1991;113:1425-37.
15. Walsh LJ, Goerdt S, Pober JS, et al. MS-1 sinusoidal endothelial antigen is expressed by factor XIIIa+, HLA-DR+ dermal perivascular dendritic cells. Lab Invest 1991; 65:732-41.
16. Goerdt S, Bhardwaj R, Sorg C. Inducible expression of MS-1 high molecular weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. Am J Pathol 1993;142:1409-22.
17. Goerdt S, Bonsmann G, Sunderköter C, et al. A unique non-Langerhans cell histiocytosis with some features of generalized eruptive histiocytoma. J Am Acad Dermatol 1994;31:322-6.
18. McDonagh JER. A contribution to our knowledge of the naevo-xantho-endotheliomata. Br J Dermatol 1912;24:86-99.
19. Koebner H. Xanthoma multiplex, entwickelt aus Naevus vasculoso-pigmentosus. Arch Dermatol Syph 1888;20: 393-412.
20. Montgomery H, Osterberg AE. Xanthomatosis: correlation of clinical, histopathologic, and chemical studies of cutaneous xanthoma. Arch Dermatol Syphilol 1938;37:375-402.
21. Kumakiri M, Sudoh M, Miura Y. Xanthoma disseminatum. J Am Acad Dermatol 1981;4:291-9.
22. Bauer A, Garbe C, Detmar M, et al. Multizentrische Retikulohistiozytose und myelodysplastisches Syndrom. Hautarzt 1994;45:91-6.
23. Mehregan DA, Winkelmann RK. Necrobiotic xanthogranuloma. Arch Dermatol 1992;128:94-100.
24. Parker F. Normocholesterolemic xanthomatosis. Arch Dermatol 1986;122:1253-1257.
25. Goerdt S, Kretzschmar L, Bonsmann G, et al. Normolipemic papular xanthomatosis in erythrodermic atopic dermatitis. J Am Acad Dermatol 1995;32:326-35.
26. Winkelmann RK, Muller SA. Generalized eruptive histiocytoma: a benign papular histiocytic reticulosis. Arch Dermatol 1963;88:586-96.
27. Gianotti R, Alessi E, Caputo R. Benign cephalic histiocytosis: a distinct entity or a part of a wide spectrum of histiocytic proliferative disorders of children? Am J Dermatopathol 1993;15:315-9.
28. Taunton OD, Yeshurun D, Jarrat M. Progressive nodular histiocytoma. Arch Dermatol 1978;114:1505-8.
29. Burgdorf WHC, Kusch SL, Nix TEJ, et al. Progressive nodular histiocytoma. Arch Dermatol 1981;117:644-9.
30. Torres L, Sánchez JL, Rivera A, et al. Progressive nodular histiocytosis. J Am Acad Dermatol 1993;29:278-80.
31. Flowers SL, Cooper PH, Landes HB. Acral persistent papular mucinosis. J AM ACAD DERMATOL 1989;21:293-7.
32. Nishiura S, Mihara M, Shimao S, et al. Cutaneous focal mucinosis. Br J Dermatol 1989;121:511-5.
33. Allen PW, Dymock RB, MacCormac LB. Superficial angiomyxomas with and without epithelial components: report of 30 tumors in 28 patients. Am J Surg Pathol 1988; 12:519-30.
34. Baraf CS, Shapiro L. Multiple histiocytomas: report of a case. Arch Dermatol 1970;101:588-90.
35. Nickoloff BJ, Wood GS, Chu M, et al. Disseminated dermal dendrocytomas: a new cutaneous fibrohistiocytic proliferative disorder. Am J Surg Pathol 1990;14:867-71.
36. Senear FE, Caro MR. Histiocytoma cutis. Arch Dermatol Syphilol 1936;33:209-26.
37. Mihatsch-Konz B, Schaumburg-Lever G, Lever WF. Ultrastructure of dermatofibroma. Arch Dermatol Forsch 1973;246:181-92.
38. Richardson BC, Lalwani ND, Johnson KJ, et al. Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol 1994;24:2640-2645.
39. Zwadlo G, Voegeli R, Schulze-Osthoff K, et al. A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp Cell Biol 1987;55:295-304.
40. Zwadlo G, Bröcker E-B, von Bassewitz D-B, et al. A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J Immunol 1985;134:1487-92.
41. Zwadlo G, Schlegel R, Sorg C. A monoclonal antibody to a subset of human monocytes found only in the peripheral blood and inflammatory tissues. J Immunol 1986;137: 512-8.
42. Goerdt S, Steckel F, Schulze-Osthoff K, et al. Characterization and differential expression of an endothelial cell-specific surface antigen in continuous and sinusoidal endothelia, in skin vascular lesions and in vitro. Exp Cell Biol 1989;57:185-92.